Description
EMERGENCY PHARMACY
Base award description: DRUGS
First action · last action
2012-01-03 · 2012-01-03
Transactions
2
First transaction's obligation
$43,419
Base + all options value (sum of deltas)
$73,436
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
SAP NON-COMPETITION
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 2 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-01-03+$43,419= $43,419
- Mod P000012012-01-03+$30,016= $73,436
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-01-03 | +$43,419 | $43,419 | DRUGS |
| Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2012-01-03 | +$30,016 | $73,436 | EMERGENCY PHARMACY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI M986PPZNJ8M8)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C26026P0671 | 260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS | $18,262 | FY2026 |
| 36C24826P1019 | 248-NETWORK CONTRACT OFFICE 8 (36C248) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C26226P1217 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6505 · DRUGS AND BIOLOGICALS | $16,333 | FY2026 |
| 36C24225P0537 | 242-NETWORK CONTRACT OFFICE 02 (36C242) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2025 |
| 36C25024P0468 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6505 · DRUGS AND BIOLOGICALS | $25,200 | FY2024 |
| 36C25723P0156 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6505 · DRUGS AND BIOLOGICALS | $3,434 | FY2023 |
Other recipients under 6505 from 246-NETWORK CONTRACTING OFFICE 6 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA24616J4018 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $28,335 | FY2016 |
| VA24616F4029 | ACTELION PHARMACEUTICALS US, INC. | 246-NETWORK CONTRACTING OFFICE 6 | $4,874 | FY2016 |
| VA24616J0011 | GLAXOSMITHKLINE, LLC | 246-NETWORK CONTRACTING OFFICE 6 | $6,390 | FY2016 |
| VA24616J3895 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $8,501 | FY2016 |
| VA24616J3970 | SANOFI VACCINES US INC. | 246-NETWORK CONTRACTING OFFICE 6 | $141,675 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA24612P1396_3600_-NONE-_-NONE- · retrieved 2026-09-26.